Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
129.54
-18.62 (-12.57%)
At close: Oct 21, 2025, 4:00 PM EDT
132.00
+2.46 (1.90%)
After-hours: Oct 21, 2025, 7:59 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $72.99 million as of October 21, 2025. Its market cap has increased by 287.65% in one year.
Market Cap
72.99M
Enterprise Value
58.43M
1-Year Change
287.65%
Ranking
Category
Stock Price
$129.54
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $72.99M, a decrease of -80.71%. That is a compound annual growth rate of -27.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 72.99M | 320.79% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.11% |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 221.98B |